IL152080A0 - Use of raloxifene or pharmaceutically acceptable salts or solvates thereof, in the preparation of a medicament for preventing breast cancer - Google Patents

Use of raloxifene or pharmaceutically acceptable salts or solvates thereof, in the preparation of a medicament for preventing breast cancer

Info

Publication number
IL152080A0
IL152080A0 IL15208002A IL15208002A IL152080A0 IL 152080 A0 IL152080 A0 IL 152080A0 IL 15208002 A IL15208002 A IL 15208002A IL 15208002 A IL15208002 A IL 15208002A IL 152080 A0 IL152080 A0 IL 152080A0
Authority
IL
Israel
Prior art keywords
raloxifene
solvates
medicament
preparation
pharmaceutically acceptable
Prior art date
Application number
IL15208002A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9624800.0A external-priority patent/GB9624800D0/en
Priority claimed from IL12202597A external-priority patent/IL122025A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to IL15208002A priority Critical patent/IL152080A0/en
Publication of IL152080A0 publication Critical patent/IL152080A0/en

Links

IL15208002A 1996-10-30 2002-10-02 Use of raloxifene or pharmaceutically acceptable salts or solvates thereof, in the preparation of a medicament for preventing breast cancer IL152080A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL15208002A IL152080A0 (en) 1996-10-30 2002-10-02 Use of raloxifene or pharmaceutically acceptable salts or solvates thereof, in the preparation of a medicament for preventing breast cancer

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2985096P 1996-10-30 1996-10-30
GBGB9624800.0A GB9624800D0 (en) 1996-11-29 1996-11-29 Methods of preventing breast cancer
US4026097P 1997-03-10 1997-03-10
IL12202597A IL122025A (en) 1996-10-30 1997-10-27 Use of raloxifene or pharmaceutically acceptable salts or solvates thereof, in the preparation of a medicament for preventing breast cancer
IL15208002A IL152080A0 (en) 1996-10-30 2002-10-02 Use of raloxifene or pharmaceutically acceptable salts or solvates thereof, in the preparation of a medicament for preventing breast cancer

Publications (1)

Publication Number Publication Date
IL152080A0 true IL152080A0 (en) 2003-05-29

Family

ID=29783277

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15208097A IL152080A (en) 1996-10-30 1997-10-27 Use of raloxifene or pharmaceutically acceptable salts or solvates thereof in the preparation of a medicament for preventing breast cancer
IL15208002A IL152080A0 (en) 1996-10-30 2002-10-02 Use of raloxifene or pharmaceutically acceptable salts or solvates thereof, in the preparation of a medicament for preventing breast cancer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL15208097A IL152080A (en) 1996-10-30 1997-10-27 Use of raloxifene or pharmaceutically acceptable salts or solvates thereof in the preparation of a medicament for preventing breast cancer

Country Status (1)

Country Link
IL (2) IL152080A (en)

Also Published As

Publication number Publication date
IL152080A (en) 2004-05-12

Similar Documents

Publication Publication Date Title
IL122025A (en) Use of raloxifene or pharmaceutically acceptable salts or solvates thereof, in the preparation of a medicament for preventing breast cancer
PL299814A1 (en) Pharmaceutical preparation inhibiting depletion of human bone tissue
AU2768699A (en) Lesion localizer for nuclear medicine
IL144668A (en) Use of a 4-h-1-benzopyran-4-one derivative for the preparation of a medicament for inhibiting smooth muscle cell proliferation
LU88842I2 (en) Nebivolol optionally in the form of a pharmaceutically acceptable salt or hydrate, in particular Nebivolol hydrochloride
IL145150A0 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU5802196A (en) Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
IL137186A0 (en) Device for inhaling medicament
DK163989A (en) Analogy process for preparing &beta-adrenergic blocking compounds, and pharmaceutically acceptable salts thereof
AU650484B2 (en) Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof
HUP9802677A3 (en) Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
GB9418064D0 (en) Medicament administration inhaler
HK1022432A1 (en) Administration of histamine for therapeutic purposes.
PL307469A1 (en) Preparation for oral administration
EP0437729A3 (en) New peptides, procedure for their preparation and their use as a medicament, especially their use as medicament against retroviruses
HU9602908D0 (en) X-ray contrast compositions containing pharmaceutically acceptable clays
IL121329A0 (en) A pharmaceutical composition for the treatment of cancer
IL152080A0 (en) Use of raloxifene or pharmaceutically acceptable salts or solvates thereof, in the preparation of a medicament for preventing breast cancer
GB8911259D0 (en) Inhalation medicament
PL325509A1 (en) Therapeutic agent for oral administration
EP0459198A3 (en) Thioalkanones, procedure for their preparation and their use
HUP0103864A3 (en) Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal administration
IL149653A0 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof
EG19689A (en) New pharmaceutical preparation for oral use
CS231590A3 (en) Preparation for hemorrhoids treatment

Legal Events

Date Code Title Description
FF Patent granted